[Use of laser nephelometry in the measurement of complement components and associated factors (author's transl)]. 1981

N Nakajima, and K Kan, and T Sugisaki

UI MeSH Term Description Entries
D009391 Nephelometry and Turbidimetry Chemical analysis based on the phenomenon whereby light, passing through a medium with dispersed particles of a different refractive index from that of the medium, is attenuated in intensity by scattering. In turbidimetry, the intensity of light transmitted through the medium, the unscattered light, is measured. In nephelometry, the intensity of the scattered light is measured, usually, but not necessarily, at right angles to the incident light beam. Turbidimetry,Nephelometry,Turbidimetry and Nephelometry
D011414 Properdin A 53-kDa protein that is a positive regulator of the alternate pathway of complement activation (COMPLEMENT ACTIVATION PATHWAY, ALTERNATIVE). It stabilizes the ALTERNATIVE PATHWAY C3 CONVERTASE (C3bBb) and protects it from rapid inactivation, thus facilitating the cascade of COMPLEMENT ACTIVATION and the formation of MEMBRANE ATTACK COMPLEX. Individuals with mutation in the PFC gene exhibit properdin deficiency and have a high susceptibility to infections. Complement Factor P,Factor P, Complement
D003165 Complement System Proteins Serum glycoproteins participating in the host defense mechanism of COMPLEMENT ACTIVATION that creates the COMPLEMENT MEMBRANE ATTACK COMPLEX. Included are glycoproteins in the various pathways of complement activation (CLASSICAL COMPLEMENT PATHWAY; ALTERNATIVE COMPLEMENT PATHWAY; and LECTIN COMPLEMENT PATHWAY). Complement Proteins,Complement,Complement Protein,Hemolytic Complement,Complement, Hemolytic,Protein, Complement,Proteins, Complement,Proteins, Complement System
D003169 Complement Inactivator Proteins Serum proteins that negatively regulate the cascade process of COMPLEMENT ACTIVATION. Uncontrolled complement activation and resulting cell lysis is potentially dangerous for the host. The complement system is tightly regulated by inactivators that accelerate the decay of intermediates and certain cell surface receptors. Complement Cytolysis Inhibiting Proteins,Complement Cytolysis Inhibitor Proteins,Complement Inactivating Proteins,Serum Complement Inactivators,Complement Inactivators, Serum,Inactivating Proteins, Complement,Inactivator Proteins, Complement,Inactivators, Serum Complement,Proteins, Complement Inactivating,Proteins, Complement Inactivator
D005779 Immunodiffusion Technique involving the diffusion of antigen or antibody through a semisolid medium, usually agar or agarose gel, with the result being a precipitin reaction. Gel Diffusion Tests,Diffusion Test, Gel,Diffusion Tests, Gel,Gel Diffusion Test,Immunodiffusions,Test, Gel Diffusion,Tests, Gel Diffusion
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

N Nakajima, and K Kan, and T Sugisaki
January 1981, Rinsho byori. The Japanese journal of clinical pathology,
N Nakajima, and K Kan, and T Sugisaki
September 1979, Rinsho byori. The Japanese journal of clinical pathology,
N Nakajima, and K Kan, and T Sugisaki
September 1976, Clinical chemistry,
N Nakajima, and K Kan, and T Sugisaki
October 1980, DTW. Deutsche tierarztliche Wochenschrift,
N Nakajima, and K Kan, and T Sugisaki
January 1979, Sangyo igaku. Japanese journal of industrial health,
N Nakajima, and K Kan, and T Sugisaki
August 1981, Rinsho byori. The Japanese journal of clinical pathology,
N Nakajima, and K Kan, and T Sugisaki
January 1981, Rinsho byori. The Japanese journal of clinical pathology,
N Nakajima, and K Kan, and T Sugisaki
April 1980, Rinsho byori. The Japanese journal of clinical pathology,
N Nakajima, and K Kan, and T Sugisaki
January 1981, Allergologia et immunopathologia,
N Nakajima, and K Kan, and T Sugisaki
November 1983, Rinsho byori. The Japanese journal of clinical pathology,
Copied contents to your clipboard!